Inaugural Brain & Spine Metastases Conference: Evolving Practice and Emerging Therapies

Release Date: February 6, 2026

Expiration Date: March 13, 2026

Activity Overview

Brain metastasis represents a significant and growing challenge in oncology, with patients often facing complex diagnostic and therapeutic hurdles. Despite recent advances, unmet needs remain regarding the early detection, optimal treatment selection, and coordination of multidisciplinary care.

This continuing medical education symposium features expert-led presentations and case-based panel discussions, providing participants with the latest updates and practical strategies for managing brain metastases.

This educational activity is an archive of the live presentation held on Thursday, January 22, 2026.

For more information about this educational activity, the faculty, and disclosures, please click here.

Target Audience

This educational activity is intended for community oncology providers, including medical oncologists, radiation oncologists, neurosurgeons, advanced practice providers, and oncology nurses who are involved in the management of central nervous system metastases in patients with lung cancer, breast cancer, and melanoma.

Learning Objectives

At the conclusion of this activity, you should be better prepared to:

• Interpret translational research advances to inform future therapeutic development and clinical decision-making in brain metastases
• Apply recent pivotal clinical trial data and emerging systemic therapy strategies to optimize treatment sequencing for brain metastases across tumor types
• Integrate advances in locoregional treatment modalities into evidence-based multidisciplinary management plans for patients with brain metastases

The staff of Physicians’ Education Resource^®, LLC have no relevant financial relationships with ineligible companies.

PER^® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or any company that provided commercial support for this activity.